|
FY2026
12 months to Mar 28, 2026
|
FY2025
12 months to Mar 29, 2025
|
FY2024
12 months to Mar 30, 2024
|
FY2023
12 months to Apr 1, 2023
|
FY2022
12 months to Apr 2, 2022
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Remeasurement of contingent consideration | |||||
| Gains on divestiture and sale of assets | |||||
| Impairment of intangible assets | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest and other expense, net | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
